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Abstract
Background: Information about the feasibility, barriers and facilitators of antimicrobial stewardship (AMS) in
residential aged care facilities (RACFs) has been scant. Exploring the prevailing perceptions and attitudes of key
healthcare providers towards antibiotic prescribing behaviour, antibiotic resistance and AMS in the RACF setting is
imperative to guide AMS interventions.
Methods: Semi-structured interviews and focus groups were conducted with key RACF healthcare providers until
saturation of themes occurred. Participants were recruited using purposive and snowball sampling. The framework
approach was applied for data analysis.
Results: A total of 40 nurses, 15 general practitioners (GPs) and 6 pharmacists from 12 RACFs were recruited. Five
major themes emerged; perceptions of current antibiotic prescribing behaviour, perceptions of antibiotic resistance,
attitude towards and understanding of AMS, perceived barriers to and facilitators of AMS implementation, and feasible
AMS interventions. A higher proportion of GPs and pharmacists compared with nurses felt there was over-prescribing
of antibiotics in the RACF setting. Antibiotic resistance was generally perceived as an issue for infection control rather
than impacting clinical decisions. All key stakeholders were supportive of AMS implementation in RACFs; however, they
recognized barriers related to workload and logistical issues. A range of practical AMS interventions were identified,
with nursing-based education, aged-care specific antibiotic guidelines and regular antibiotic surveillance deemed most
useful and feasible.
Conclusions: Areas of antibiotic over-prescribing have been identified from different healthcare providers’ perspectives.
However, concern about the clinical impact of antibiotic resistance was generally lacking. Importantly, information
gathered about feasibility, barriers and facilitators of various AMS interventions will provide important insights to
guide development of AMS programs in the RACF setting.
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Background
There is increasing evidence that the elderly population
in residential aged care facilities (RACFs) serves as an
important reservoir for multidrug-resistant (MDR) or-
ganisms [1,2], with high antibiotic use causing selective
pressure and encouraging the emergence of various
MDR organisms [3,4]. As antibiotic resistance in bacteria
increases and the development pipeline of new antibiotics
declines, judicious use of antibiotics through antimicrobial
stewardship (AMS) programs has become critical across
all parts of the healthcare system, including the RACF
setting. Formal AMS programs have been increasingly
established in the acute-care hospital setting, but remain
relatively uncommon in RACFs [5].
Essentially, the need for AMS and the potential areas for
AMS interventions are reliant upon existing antibiotic use
and resistance patterns. For example, a study in Australian
RACFs has shown less frequent use of broad-spectrum
antibiotics such as fluoroquinolones [6] compared to
long-term care facilities in the United States (US), where
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fluoroquinolone prescribing is widespread [7,8]. Likewise,
the magnitude of antibiotic resistance has been reported
to vary across RACFs in different geographical areas [9].
Not surprisingly, surveys involving Nebraska and Irish
long-term care facilities have reported very distinctive AMS
practices, presumably because AMS interventions are tai-
lored according to the needs and resources of individual
institutions in different geographical areas [10,11].
International guidelines for infection control and pre-
vention have strongly recommended initiation of AMS
programs in the RACF setting [12]; however, practical
models for AMS in this setting remain poorly delineated.
Adopting hospital-based AMS programs in the RACF
setting may be unrealistic due to differences in organ-
izational resources and antibiotic prescribing patterns
between these two healthcare settings. Recent studies
from the US reported that AMS interventions involving
multidisciplinary teams with regular audits are effective
in reducing inappropriate antibiotic prescribing in the
long-term care setting; however, these studies were mainly
single centre and their sustainability remains in question
[13,14]. To date, information about the feasibility, barriers
and facilitators of AMS programs in RACFs has been scant.
The perceived need and readiness for AMS interventions
in the RACF setting can be explored via qualitative re-
search that allows in-depth investigation into the social
and environmental determinants of antibiotic prescribing
practices [15]; however, such work had previously not been
undertaken. In preparation for developing practical and
sustainable AMS models in this setting, the current study
explored the attitudes and perceptions of key healthcare
providers towards AMS interventions in Australian RACFs.
Methods
Study population and setting
This is part of a larger study exploring key healthcare
providers’ views about improving antibiotic use in the
RACF setting. The study targeted primarily high-level care
RACFs (i.e. nursing homes) affiliated with four major pub-
lic healthcare service networks within metropolitan and
regional Victoria, Australia. These residential care facilities
deliver 24-hour nursing care to elderly residents requiring
significant assistance in their activities of daily living. There
was no institutional policy for antibiotic prescribing in any
of the RACFs; however, intravenous antibiotic therapy
when required is normally delivered via specialized support
from hospitals.
Three major groups of healthcare providers servicing
the participating RACFs were invited to participate, namely
general practitioners (GPs), nurses and pharmacists. At
these RACFs, the medical care is provided by off-site GPs
(equivalent to family physicians in the US) from different
practices, who visit residents periodically or upon request.
There are significant roles for nursing staff in daily care of
residents, including ringing GPs to request medical as-
sessment. Prescription medicines, including antibiotics,
require an order from the GPs and are supplied by external
community pharmacies. Medication review for individual
residents [known as Residential Medication Management
Review (RMMR)] is normally performed on an annual basis
by consultant pharmacists, however this does not involve
audit of short-term antibiotic use.
Participant recruitment and data collection
Institutional ethics approvals from the human research
ethics committees of all participating healthcare service
networks and Monash University were obtained prior to
participant recruitment. A combination of purposive and
snowball sampling strategies were used for recruitment
of different healthcare providers [16]. The aforementioned
healthcare professionals with routine involvement in the
antibiotic prescribing process were intentionally approached
(i.e. purposive sampling), and some other participants
were also recruited through recommendation by initial
informants (i.e. snowball sampling). Informed consent was
obtained from individual participants, and participation
was voluntary.
Nursing staff in different clinical positions [senior ex-
ecutive nurses, nurse unit managers (NUMs), registered
nurses (RNs)] were involved in either one-on-one inter-
views or focus groups. All NUMs and RNs were involved
in daily care of residents, whilst the executive nursing staff
were responsible at the policy-making level for quality
improvement of resident care. Face-to-face or phone
interviews were conducted with the GPs and pharma-
cists, depending on their preference. We used several
triangulation strategies; we sought information from
different stakeholders’ perspectives (i.e. data triangulation),
performed onsite observation on the organizational work-
flow and documentations related to antibiotic prescribing
(i.e. methodological triangulation), and explored views of
participants from RACFs in different locations (i.e. envir-
onmental triangulation).
All interviews were conducted using a semi-structured
interview guide, which was tailored to different healthcare
providers (Additional files 1, 2 and 3). The interview guide
was divided into three main domains (antibiotic pre-
scribing, antibiotic resistance and AMS) whilst allowing
flexibility to pursue particular issues by more in-depth
discussion as they emerged from the interviews. All dis-
cussions were moderated by one or two interviewers
(CJL and MK). Recruitment of key stakeholders from
the four healthcare networks continued until data sat-
uration (i.e. when no new relevant themes emerged).
Participant recruitment and interviews were conducted
between January and July 2013. All interviews were
audio-recorded and transcribed verbatim by an inde-
pendent, professional transcribing service.
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Data analysis
Data were analyzed for emergent themes using the frame-
work approach, as described elsewhere [17,18]. This
approach involved five stages: (i) familiarization with
the data collected by detailing the interview recording
and transcripts; (ii) identifying key issues and themes
that construct a thematic framework; (iii) indexing (coding
the data) into themes; (iv) charting by rearranging indexed
data according to the thematic framework; and (v) map-
ping and interpreting the data. Data management of inter-
view transcripts and recording was facilitated using Nvivo®
9.0 (QSR, Melbourne). All transcripts were verified against
audio recordings by CJL and MK. Data analyses were car-
ried out independently by the two researchers (CJL and
MK) for cross-validation purpose, with peer-debriefing at
regular intervals. Themes and codes were discussed at
regular meetings involving all co-authors, where discre-
pancies were resolved and themes were finalized.
Results
Twelve high-level care RACFs within the four major
healthcare networks participated. From these RACFs, 40
nursing staff [four executive nurses, 15 nurse unit managers
(NUMs), and 21 registered nurses (RNs)], 15 GPs and six
pharmacists consented to participate in the study. The
majority of participants were interviewed individually,
with 15 RNs participating in three focus groups (range
4–6 RNs per focus group). All except four interviews were
conducted face-to-face with participants. The demographic
characteristics of the participants are described in Table 1.
Five major themes that illustrate the prevailing perceptions
and attitudes towards the need and readiness for AMS
program in this setting emerged:
Perceptions of current antibiotic prescribing behaviour
There were mixed views about existing antibiotic prescrib-
ing behavior (Table 2). Several nurses and pharmacists
believed that current antibiotic use in RACFs was not
excessive; most indicated that perceived patient frailty or
behavioral changes often precluded the potential strategy
of withholding antibiotic treatment and observing for
development of further clinical signs. Likewise, a few GPs
felt that empiric prescribing of broad-spectrum antibiotics
was fairly reasonable for the elderly population in RACFs
(Table 2, Q1-Q3). In contrast, twelve of 15 GPs perceived
that there was over-prescribing of antibiotics, with many
admitting to prescribing antibiotics “just in-case” in light
of the potential risk for patient deterioration if treatment
was not initiated. A number of GPs indicated that pressure
from nursing staff and family members was an important
reason leading to unnecessary antibiotic prescribing (Table 2,
Q4- Q5). Relatively fewer nurse participants were concerned
about excessive antibiotic use among RACF residents.
Those nurses who were concerned felt that there was
liberal prescribing of antibiotics for futile reasons inclu-
ding viral illness and asymptomatic bacteriuria. Some
were concerned about frequent empiric antibiotic pre-
scribing without microbiological investigations to confirm
causative organisms (Table 2, Q6-Q7). The main concern
raised by participating pharmacists was about prolonged
durations of antibiotic treatment (Table 2, Q8). They indi-
cated that antibiotics were generally prescribed for an
average of 7–10 days; however, it was not uncommon for
antibiotics to be administered for longer periods when
doctors had not documented a planned cessation date
for treatment of acute infections, or where antibiotics
were utilized for long-term prophylaxis against infection.
Perceptions of antibiotic resistance in RACFs
There were also mixed perceptions about antibiotic
resistance (Table 2). Several GPs claimed they had not
encountered many MDR organisms within their clinical
practice; however, they admitted that cultures of relevant
clinical samples were seldom requested. Similarly, the
majority of nursing staff did not see this as an import-
ant issue, as they believed it was encountered less fre-
quently than in the hospital setting, and often did not
change management of residents within the RACFs
(Table 2, Q9-Q10). In comparison, about half of the GPs
believed that antibiotic resistance was an emerging issue
in RACFs, reporting that MDR organisms were often seen
in residents with recurrent urinary tract infections (espe-
cially those with indwelling urinary catheters), long-term
antibiotic prophylaxis and chronic wound colonization
(Table 2, Q11-Q12). However, only a minority of GPs were
concerned that antibiotic resistance would affect their
choice of empiric antibiotics. Whereas from the nurses’
perspective, only a small proportion were worried about
the increasing rates of MDR organisms; their main con-
cerns were about low staff awareness and inadequacy of
existing infection control efforts in preventing MDR
organism transmission as opposed to clinical impact on
residents (Table 2, Q13).








≤40 years 11 (28) 0 2 (33)
>40 years 29 (73) 15 (100) 4 (67)
Female, n (%) 37 (93) 7 (47) 4 (67)
Mean years of work
experience in RACF, (range)
13 (0.75 - 43) 22 (4–40) 8.5 (4–12)
Locations, n (%)
Metropolitan 32 (80) 10 (67) 5 (83)
Regional 8 (20) 5 (33) 1(17)
NOTE. GPs = general practitioners; RACF = residential aged care facility.
Lim et al. BMC Infectious Diseases 2014, 14:410 Page 3 of 10
http://www.biomedcentral.com/1471-2334/14/410
Attitude towards and understanding of AMS
The majority of participating nursing staff were unaware
of the concept of AMS. In comparison, more GPs and
pharmacists were aware of AMS, although they generally
felt that AMS was relatively new in the RACF setting.
AMS refers to integrated activities that help to optimize
antibiotic therapy, ensuring the best clinical outcomes
whilst minimizing the risk for the emergence of antimicro-
bial resistance. When this concept of AMS was explained,
in general, all key stakeholders were supportive of AMS
programs in RACFs. Amongst GPs, the main value of AMS
was thought to be in promoting evidence-based practices
for antibiotic prescribing in this setting (Table 3, Q1).
All executive nursing staff felt that AMS was applicable,
and welcomed future intervention as part of quality im-
provement strategies in their RACFs (Table 3, Q2).
Likewise, the NUMs and RNs felt that AMS interventions
would be helpful as an additional source of educational
support for nurses, given their relative lack of knowledge
regarding antibiotic use (Table 3, Q3-Q4). The pharmacists
were also supportive of AMS interventions, particularly
to achieve more uniformity in antibiotic prescribing and
consistency with adopting guidelines (Table 3, Q5-Q6).
Perceived barriers to and facilitators of AMS interventions
A number of perceived barriers and facilitators in relation
to implementation of AMS interventions were raised.
From the GPs’ perspective, several raised concerns about
the potential for doctor autonomy to hinder acceptance of
institutional policies and guidelines. Heterogeneity in pre-
scribing practices amongst GPs from different practices
pose another barrier, thus having fewer GPs with greater
patient loads working in each facility would promote more
consistent prescribing practices (Table 3, Q7-Q8). Nursing
Table 2 Perceptions of current antibiotic prescribing behaviour and antibiotic resistance in the residential aged care
facility setting
Themes Positive views Negative views
Perceptions of current
antibiotic prescribing behaviour
Q1. “It [Antibiotic use] is probably about right, I’ve sort
of never had an issue where I’ve thought ‘oh no they
should have been on antibiotics or yeah they should
not be’, and as I said a lot of our [residents], you’ve
got to weigh up the [change of] behaviours and
the risks to everyone.” (NUM 13, 30 yr)
Q4. “I guess the other thing is that we know particularly
in the elderly, it’s better to get in early and treat. So if
you think should I/shouldn’t I, then treat, you know,
rather than wait until they get crook. And if it’s a bit
of over treatment so be it.” (GP 7, 30 yr)
Q2. “It’s usually pretty reasonable. Because bearing in
mind that where it may be a viral infection initially, a
lot of these people are frail, non-ambulant and will
go on to a secondary bacterial infection.” (Consultant
pharmacist 5, 12 yr)
Q5. “Probably an over use, because we get pressured
by nursing staff mostly to prescribe, they're very reluctant
to let anyone with a cold be untreated.” (GP 1, 32 yr)
Q3. “We don’t have the luxury of if this antibiotic doesn’t
work we’ll try something else, often they [RACF residents]
can go down so fast…You don’t have that second chance,
so you’ve really got to hit them [with broader spectrum
antibiotics].” (GP 13, 30 yr)
Q6. “It’s increased for everything; someone sneezes they
get antibiotics, somebody’s urine smells or you know it
lights up a stick, they get antibiotics.” (NUM14, 12 yr)
Q7. “… some GPs continually use the same antibiotics,
you know people are put on the same antibiotics for
maybe 2 months….they don’t think to go and check to
see if they're resistant or whatever any more.” (NUM 7, 9 yr)
Q8. “Well, there might be an infection, they just go in
there and write up a broad-spectrum [antibiotic] and have
it for 2 weeks regardless of what the infection is. They're
not too much adhering to the [Australian national] antibiotic
guidelines.” (Community pharmacist 1, 7 yr)
Perceptions of
antibiotic resistance
Q9. “I wouldn’t say there's been any change [of antibiotic
resistance trend] in all the time I’ve practiced medicine…
Probably I don’t do that much pathological testing, but I
don’t see it as having been an issue.” (GP 12, 5 yr)
Q11. “I would think so, yes, I think you get more of the
really unusual urine reports and unusual bacteria or ones
with multi resistance, yeah for sure…I guess anywhere
where there's a lot of antibiotic use there's going to be
a lot of resistance generated.” (GP 1, 32 yr)
Q10. “In the nursing home setting it’s not a major issue…
I’d have to look up their [residents’] notes to see [if they
have MDR organism infection or colonisation]…It’s not a
big issue for us because we are not a hospital setting, so
we wouldn’t isolate someone for example who’s VRE
[vancomycin-resistant enterococci] positive.”
(NUM 1, 13 yr)
Q12. “From a wound swab point of view, you're more likely
to get a resistant bug in an aged care facility than you are
in the community…” (GP 2, 20 yr)
Q13. “It used to be a really big deal … if someone had
MRSA, ‘oh my God’ you know it was the yellow bags and
everything came out and we isolated them and we would
scrub. Now I mean we wouldn’t even blink if [we see these
MDR organisms]. And I don’t think the younger staff realise
too the implications of someone having MRSA. But now it's
nothing, no one really cares.” (NUM 10, 23 yr)
NOTE. Q = quotes extracted from interview transcripts; NUM = nurse unit managers; GP = general practitioner; yr = years (of work experience in RACF).
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Table 3 Perceptions of implementation of antimicrobial stewardship from different healthcare providers’ perspectives




Q1. “[We know] that the resistant organisms are
becoming more and more of a bigger problem.
And our aged care group have got an increased
incidence of side effects from the antibiotics,
and it's not uncommon for us to end up with
someone with diarrhoea for example plus or
minus Clostridium difficile colitis. So you know,
thrush is a big problem in this sector as well
through antimicrobials. So there are lots of
reasons why we should try to adhere to the
best practice.” (GP 14, 27 yr)
Q2. “Yes, I think it’s certainly applicable and I think it’s
been identified that we need to improve our practice.
We would be prepared to do some sort of a follow-up
project…” (Executive nurse 4, 12 yr)
Q5. “It [Antimicrobial stewardship] is needed…In most cases,
the registered nurses, or the enrolled nurses, cannot make a
decision about whether an antibiotic is needed or not.”
(Consultant pharmacist 5, 12 yr)
Q3. “It would be good, so only right antibiotics being used and
only [prescribed to] the right resident. Only residents really need
to be given [antibiotics] rather than things like behaviour change
is [presumed to be] UTI and give antibiotics.” (NUM 4, 20 yr)
Q6. “I think it’s fantastic because the next step, aged care, is
like a hospital or if you wanted to say that, where they are
in a controlled environment where their medications are, you
know, freely given but they are [supposed to be] given to
them accordingly.” (Community Pharmacist 4, 4 yr)
Q4. “To be honest many of us don’t think we are overusing
antibiotics in cases where it might be over using antibiotics…
So if you want to change it you should be teaching and
educating us.” (RN 7, 2 yr)
Perceived barriers
and facilitators
Q7. “I think that there is always the question
of … doctor autonomy, you know, that doctors
like to be their own boss, don’t like to be
dictated to.” (GP 8, 20 yr)
Q9. “In residential aged care there's a burden of workload, a
burden of lots of things, documentation etc., so there's always
a risk of ‘oh this is just another thing’.” (Executive nurse 2, 4.5 yr)
Q13. “So obviously in hospital setting it’s a bit more intimate
because the doctors and the pharmacists are liaising with
one another quite frequently as opposed to a community
pharmacist and the aged care doctors.” (Community
pharmacist 4, 4 yr)
Q8. “There's too many people [GPs] dabbling…
So I think if we got more people doing [full-time]
aged care, or having more residents in the one
facility, a lot of these problems within residential
care will diminish, because you’ll get more
consistent treatments.” (GP 14, 27 yr)
Q10. “So GPs [are] in their own practices, they have their own
perhaps ways of doing things… that may present some barriers
to introducing something like that…” (NUM 1, 13 yr)
Q14. “I’d be more than happy to use resources that you provide
on you know best practice, guidelines, whatever, and then
educate [nursing] staff. I mean I would have no problem in
that and yes there is a role.” (Consultant pharmacist 6, 12 yr)
Q11. “What we’ve found in the past with other similar things is
to have a champion, where we have a couple of people trained
up who drive the program, and bring their peers on board if you
like.” (Executive nurse 3, 10 yr)
Q12. “Obviously all the parties need to have that education…
we need to get it across to everyone, so I think nursing staff are
the best people to do that, to go up and to go down at the
same time.” (NUM 8, 12 yr)



















staff had mixed attitudes. The executive nursing staff
anticipated that AMS interventions might not be easily
accepted by nursing staff in view of their high workload.
Conversely, most of the NUMs did not foresee major
resistance from nursing staff given their past experiences
with other quality improvement initiatives, instead, having
more concern about GP acceptance of any AMS interven-
tions (Table 3, Q9-Q10). It emerged that nursing staff
would need to play an essential role in delivering any
future AMS intervention, with facilitation of AMS pro-
grams being driven by on-site staff such as NUMs or
clinical nurse coordinators. The nursing staff would be
in a good position to disseminate relevant information
to family members and GPs (Table 3, Q11-Q12). Both
community and consultant pharmacists perceived several
logistical barriers to providing additional clinical support,
in particular, their lack of on-site availability, inadequate
access to patients’ clinical information, and limited com-
munication with GPs. All consultant pharmacists were
willing to undertake additional clinical roles; however, they
acknowledged that current funding resources offered little
prospect for this to occur (Table 4, Q13-Q14).
Feasible AMS interventions
Three major areas of AMS interventions emerged as
potentially useful and practical in the RACF setting
(Table 4). The most commonly suggested intervention was
ongoing education to nurses, GPs and family members
of residents, with the objective of promoting awareness
of judicious antibiotics use amongst those working in
the RACFs (Table 4, Q1-Q3). Various suggestions for how
this could be achieved were identified, including in-service
training (for nurses), web-based education, provision of
educational material in poster or brochure form, and
invited speaker sessions. Another area identified was the
emphasis on evidence-based practice around aged-care
specific management. Importantly, more than half of the
GPs indicated a need for aged care-specific antibiotic
guidelines, as current guidelines were thought to be lack-
ing evidence and recommendations specific to the aged
care population. The nursing staff perceived a need for
consistent, RACF-based guidance and support on the
matter of infection management; for example, a clinical
protocol guiding the management of symptomatic versus
asymptomatic bacteriuria was frequently recommended
(Table 4, Q4-Q6). The third main potential area for future
AMS identified was surveillance and auditing of antibiotic
use. It was believed that monitoring of antibiotic use
with regular feedback to GPs would be helpful to guide
and target reduction of specific antibiotic use, and con-
sultant pharmacists were deemed most suitable to per-
form such activity (Table 4, Q7-Q9). In contrast to
more proactive hospital-based AMS interventions (such
as pre-authorization of broad-spectrum antibiotics or
review by infectious diseases teams), passive surveillance
of antibiotic use was thought to be sufficient and more
practical in this setting. Other suggestions included
additional staff resources via introduction of the nurse
practitioner model, and re-institution of aged care interest
groups to further support and educate GPs.
Discussion
To our knowledge, this is the first study exploring the
perceptions and attitudes of a range of healthcare pro-
viders towards antibiotic prescribing behaviour, anti-
biotic resistance, and AMS implementation in the RACF
setting. A greater proportion of GPs and pharmacists
than nursing staff felt that there was over-prescribing of
antibiotics, suggesting a lack of awareness amongst nurses
about potential antibiotic misuse among this population.
Antibiotic resistance and the emergence of MDR organisms
were perceived as more of a concern from the infection
control perspective as opposed to impacting empiric anti-
biotic selections. Additionally, this study has highlighted
the prevailing attitudes amongst key healthcare providers
that AMS interventions were needed and deemed useful in
the RACF setting. A number of perceived barriers to AMS
programs were identified, in particular, nursing staff work-
load and the logistical issues of off-site GPs and pharma-
cists. A range of potential AMS interventions have been
suggested to provide insights into feasible AMS model for
the RACF setting.
Published data describing the key stakeholders’ views of
antibiotic prescribing and antibiotic resistance have mainly
focused on the general practice setting, with limited infor-
mation from the RACF setting [18,19]. A study by Walker
et al. has explored the views of the physicians and nurses
about antibiotic prescribing in Canadian RACFs but it
focused specifically on treatment for asymptomatic bac-
teriuria, reporting that education about asymptomatic
bacteriuria was viewed as an important priority by both
physicians and nurses [20]. In addition to concern about
antibiotic treatment for asymptomatic bacteriuria, our
study also identified a need for education to target other
infective issues, including the widespread prescribing
for viral upper respiratory tract infections, and repeated
or prolonged antibiotic use without microbiological inves-
tigation. The current study found that the overuse of anti-
biotics in the Australian RACFs context was thought to
be mainly related to widespread empiric prescribing
or unnecessary antibiotic treatment, as opposed to the
over-prescribing of broad-spectrum antibiotics such as
intravenous antibiotics and oral fluoroquinolones that
was more frequently reported in the US studies [7,8].
Previous studies have reported that increasing the
awareness about antibiotic resistance would potentially
influence GPs’ decisions in selecting antibiotics, underlining
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Table 4 Feasible antimicrobial stewardship interventions deemed useful by three key stakeholders
AMS interventions
deemed most useful
Representative quotes from different healthcare providers’ perspectives
GPs Nurses Pharmacists
Education Q1. “They (GPs) are very much used to their general
practice, but the treatment of geriatric case load is
different…well obviously educating the GPs is really
important.” (GP 14, 27 yr)
Q2. “We all talk about the 5 rights of medication, and I’m
sure there are 5 rights about antibiotic use. So you know
just reminding people, are we creating a superbug, are
we giving antibiotics when they're not required.” (NUM
8, 12 yr)
Q3. “But if we could educate the nurses who are there
every day, you know at the coalface, when they could
see the doctor’s keeping prescribing [antibiotics], they
could just bring it up with the GP…” (Consultant
pharmacist 2, 12 yr)
Policy and
guidelines
Q4. “… the [antibiotic] therapeutic guidelines might say
okay for a pharyngitis you might use this [antibiotic], in a
penicillin allergic patient you’ll use this or for a community
acquired pneumonia you’ll use this, and for a hospital
acquired pneumonia this is what we recommend…I think
it’d be useful if they [guidelines] were there, to sort of say
well you know based on trials we’ve found that nursing
home patients need two courses or they don’t need any
more than the regular.” (GP 3, 12 yr)
Q5. “Some sorts of protocol like when, say for UTI, when
to start antibiotics, what stage of infection, signs and
symptoms you have to really go on antibiotics. For
respiratory infections when the person has to go on
antibiotics, and when we see what kind of signs and
symptoms definitely should be on antibiotics or something
like that, would be helpful I think.” (RN 14, 9 months)
Q6. “So if you have got universal policies on infection
control and antibiotic uses, you have got a bit of a
chance [to facilitate consistent antibiotic prescribing




Q7. “Because well I always prescribe Abbocillin® for
tonsillitis but it’s amazing how many people prescribe
Amoxil® or Ceclor® or Keflex® or something like that, you
know. And yeah so obviously that kind of auditing is a
good idea.” (GP 8, 20 yr)
Q8. “I think it's helpful to do [antibiotic surveillance],
because we do know that sometimes people are left on
medications for too long, and unless someone’s got that
awareness of it to say ‘I don’t think this might be
working’.” (Executive nurse 3, 10 yr)
Q9. “Just getting a general idea and another set of eyes
on the actual outcome of the patient would definitely
help with the prescribing habits as well… I believe that
obviously RMMR [consultant] pharmacists they can come
in because they get access more to clinical notes than
what a community pharmacist would do.” (Community
pharmacist 4, 4 yr)




















the importance of knowledge about MDR organisms in
assisting clinical decisions [18,21,22]. Furthermore, educa-
tion that promotes awareness about antibiotic resistance
is likely to encourage more microbiological testing to
identify causative organisms before initiating antibiotic
treatment. Several international guidelines suggest that
provision of antibiograms by local microbiology laborator-
ies as fundamental requirement for an AMS program in
the RACF setting [12,23]. However, the need for antibio-
grams to guide empiric antibiotic therapy has not been
suggested as a useful or practical AMS initiative by any
healthcare provider that participated in this study. The
feasibility of this strategy may be hindered by limited
microbiological investigations and involvement of multiple
external pathology laboratories.
AMS interventions in the RACF setting have been few
despite mounting evidence of inappropriate antibiotic
prescribing among this elderly population [9,24]. Existing
guidelines about the implementation of AMS have pri-
marily been limited to the acute-care hospital setting [25].
An intensive form of AMS intervention with involvement
of infectious diseases physicians or clinical pharmacists
has been adopted in Veterans Affairs long-term care facil-
ities in the US [14]; however, most key stakeholders in the
present study indicated that such AMS interventions are
not practical or necessary in the Australian RACF setting.
From the current work, an approach to AMS tailored to
the needs of key healthcare providers in RACFs is pro-
posed (Table 5). Multifaceted interventions are likely to be
most effective; however, such interventions should be
tailored to the resources and expertise in individual RACFs.
Overall, the important role of nursing staff in the day-to-
day practice of AMS in RACFs cannot be under-estimated,
and could function effectively if supplemented by educa-
tion, infection management algorithms and training in the
use of antibiotic utilization surveillance.
This study has predominantly involved high-level care
hospital-affiliated RACFs. There may be differences in
antibiotic prescribing behaviour in comparison to low-
level care or private RACFs, and thus this study could be
replicated more widely to other RACF setting for further
exploration. Given the differences in long-term healthcare
delivery models between different countries [26], the find-
ings and suggestions in the current study may not be
generalizable outside the Australian setting. Nevertheless,
the current findings are likely to be of interest to many,
especially those who are closely affiliated with RACFs.
Participation in this study was voluntary, thus the expres-
sion of personal perceptions may be skewed towards those
who are more involved with or concerned about AMS. In
order to minimize the potential bias, we have explored
both the positive and negative views from a range of key
stakeholders, and continued the recruitment and data
analysis until we achieved data saturation amongst all
stakeholder groups.
Conclusions
In summary, AMS interventions have been deemed
applicable and useful by the key stakeholder groups in-
volved in the provision of healthcare in RACFs. Potential
Table 5 Potential areas of focus for antimicrobial stewardship interventions as proposed by study participants
AMS interventions Potential areas of focus
Nursing staff education and training -Reinforcement of issues about antibiotic use, antibiotic resistance and benefits of
antimicrobial stewardship
-Education sessions as part of in-service training, via online training modules, awareness
campaigns, etc.
Aged care-specific infection management
algorithms for nursing staff
-Flow charts to guide appropriate initial testing of residents, as well as guidance with regard to
conditions that may be observed versus those requiring immediate contacting of prescribers
-Targeted management of common infections, in particular, urinary and respiratory tract
infections
Aged care-specific antibiotic treatment guidelines -Development of evidence-based aged care antibiotic treatment guidelines (with recommendations
about appropriate dosages and duration of therapy)
-Education to prescribers through online updates or distribution of newsletters, highlighting
evidence-based prescribing practices
Regular surveillance of antibiotic use by consultant
pharmacists
-Passive surveillance and audit of antibiotic use, with regular feedback to the prescribers
-Documentation of individual residents’ prior antibiotic exposure over time, supplemented
by antibiotic susceptibility results to guide prescribing decisions
Improved communication about decisions related
to antibiotic prescribing
-Early discussion with residents and/or families about antibiotic use during acute events and
terminal illness as part of advanced care planning
-Proper handover from locum doctors to regular GPs regarding antibiotics prescribed after
hours for further review
-Faxing of treatment plans for phone ordering of antibiotics via antibiotic ordering form with
clear indications for treatment and planned duration of treatment
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barriers and facilitators for AMS interventions have been
highlighted, providing important information to guide al-
location of future AMS resources. More importantly, the
major areas of AMS deemed most needed and practical in
the RACF setting have been identified to guide the devel-
opment of a feasible AMS model.
Additional files
Additional file 1: Semi-structured interview guide for general
practitioners.
Additional file 2: Semi-structured interview guide for nursing staff.
Additional file 3: Semi-structured interview guide for pharmacists.
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